BCL2L1 and glioma: Conversely, another publication proposes that simultaneous inhibition of Bcl-2, Bcl-w, and Bcl-xL by ABT-263, combined with the down-regulation of Mcl-1, significantly reduces the viability of glioma cell lines41.